Dr Yong Du

Qualifications

MBBS MSc PhD FRCP

GMC number: 6127896

Practising since: 2008

Specialties

Nuclear Medicine

  • Overview
Enquire now

Or call us on

020 8247 3351

About

Dr Yong Du graduated from Shandong Medical University and was awarded a PhD in Cancer Sciences at University of Southampton for his work on lymphoma.

Dr Du completed his nuclear medicine specialist training at the Institute of Nuclear Medicine, University College Hospital in London. He was the first recipient of the national HEFCE Clinical Senior Lectureship Award in the Nuclear Medicine specialty, awarded in June 2009.

In conjunction with his clinical practice, he has research interests to further assess the role, efficacy and limitations of PET CT in various cancers, to optimise its use, and inform tailored treatments for patients.

Dr Yong Du also has extensive experience in radionuclide targeted therapy. He is interested in combining the fast advancing functional imaging technology with multidisciplinary expertise to help develop and optimise radionuclide targeted therapy for cancer patients.

In collaboration with researchers across the country, Dr Yong Du has led and contributed to a number of international and national studies, has published first-authored research papers in high-impact oncology journals including Journal of Clinical Oncology, Blood and Cancer Research.

Special interests

  • Nuclear medicine: both diagnostic and theraputic
  • PET/CT imaging
  • Radionuclide targeted therapies: bone metastases, lymphoma, NET, thyrotoxicosis and thrombocytosis
  • SPECT & SPECT/CT imaging

Treatments and tests offered by Dr Yong Du at Nuffield Health

  • Lutetium-177 PSMA therapy
  • Positron emission tomography (PET) scan

Locations Dr Yong Du works with

Related experience

Memberships

  • Trustee of the British Nuclear Medicine Society

Other posts held

  • The Royal Marsden NHS Foundation Trust
  • French AERES Committee
  • NCRI PET Research Network
  • BNMS Radionuclide Targeted Therapy Committee
  • NCRI Clinical and Translational Radiotherapy (CTRad) Research Working Group

Declaration

Dr Yong Du does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Dr Yong Du does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Dr Yong Du does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.